GB1421108A
(en)
*
|
1973-09-07 |
1976-01-14 |
Exxon Research Engineering Co |
Sulphurised phenols
|
NZ205559A
(en)
*
|
1982-09-23 |
1987-08-31 |
Merck Frosst Canada Inc |
Leukotriene antagonists, pharmaceutical compositions, and intermediates
|
DE3366107D1
(en)
*
|
1982-09-30 |
1986-10-16 |
Merck Frosst Canada Inc |
Leukotriene antagonists, their production, and compositions containing them
|
EP0152022B1
(fr)
*
|
1984-02-03 |
1988-10-05 |
Ciba-Geigy Ag |
Di-[(hydroxyphényl substitué)thio]-alkanes et -cycloalkanes ainsi que compositions les contenant
|
US4560799A
(en)
|
1984-02-03 |
1985-12-24 |
Ciba-Geigy Corporation |
Tri- and Tetra-(substituted hydroxyphenylthio) alkane and cycloalkane stabilizers and stabilized compositions
|
US5401883A
(en)
*
|
1987-01-20 |
1995-03-28 |
Merrell Dow Pharmaceuticals Inc. |
Process for preparing 2,6-di-tertiarybutyl-4-mercaptophenol and 4,4'-isopropylidenedithio-bis-(2,6-di-tertiarybutylphenol)
|
CA1339222C
(fr)
*
|
1987-01-20 |
1997-08-05 |
Merrell Dow Pharmaceuticals Inc. |
Methode pour preparer le 2,6-di-tert-butyl-4-mercaptophenol et le 4,4'-isopropylidenedithio-bis-(2,6-di-tert-butylphenol)
|
US4975467A
(en)
*
|
1987-03-17 |
1990-12-04 |
Merrell Dow Pharmaceuticals Inc. |
Method of inhibiting interleukin-1 release and alleviating interleukin-1 mediated conditions
|
US4954528A
(en)
*
|
1988-12-08 |
1990-09-04 |
Merrell Dow Pharmaceuticals Inc. |
Hypocholesterolemic use of bis(3,5-di-tertiary-butly-4-hydroxyphenylthio)methane
|
US4900757A
(en)
*
|
1988-12-08 |
1990-02-13 |
Merrell Dow Pharmaceuticals Inc. |
Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-tertiary-butyl-4-hydroxyphenylthio)methane
|
DE69031913T2
(de)
*
|
1989-07-14 |
1998-07-09 |
Biodor Us Holding Corp |
Antivirale mittel
|
US4959392A
(en)
*
|
1989-07-24 |
1990-09-25 |
Merrell Dow Pharmaceuticals Inc. |
Method of treating diabetes mellitus
|
US5677291A
(en)
*
|
1993-12-10 |
1997-10-14 |
Hoechst Marion Roussel, Inc. |
Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
|
US5795876A
(en)
*
|
1996-04-30 |
1998-08-18 |
Hoechst Marion Rousssel, Inc. |
Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2, 6-di-alkyl-4-silyl-phenols
|
US6114572A
(en)
*
|
1996-11-20 |
2000-09-05 |
Hoechst Marion Roussel, Inc. |
Substituted phenols and thiophenols useful as antioxidant agents
|
AU2002300328B2
(en)
*
|
1997-05-14 |
2006-04-13 |
Atherogenics, Inc |
Compounds and methods for the inhibition of the expression of VCAM-1
|
CN1275596C
(zh)
|
1997-05-14 |
2006-09-20 |
阿特罗吉尼克斯公司 |
普罗布考单酯在制备用于治疗心血管疾病和炎性疾病的药物中的应用
|
EP1695959A1
(fr)
*
|
1997-05-14 |
2006-08-30 |
Atherogenics, Inc. |
Composes et methodes d'inhibition de l'expression de VCAM-1
|
US6852878B2
(en)
|
1998-05-14 |
2005-02-08 |
Atherogenics, Inc. |
Thioketals and thioethers for inhibiting the expression of VCAM-1
|
US6670398B2
(en)
|
1997-05-14 |
2003-12-30 |
Atherogenics, Inc. |
Compounds and methods for treating transplant rejection
|
AU2006202461B2
(en)
*
|
1997-05-14 |
2009-12-03 |
Atherogenics, Inc. |
Compositions and methods for the inhibition of the expression of VCAM-1
|
US6121463A
(en)
*
|
1997-06-24 |
2000-09-19 |
Hoechst Marion Roussel, Inc. |
Alkyl-4-silylheterocyclic phenols and thiophenols useful as antioxidant agents
|
US6133467A
(en)
*
|
1997-06-25 |
2000-10-17 |
Hoechst Marion Roussel, Inc. |
2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol
|
WO2005102323A2
(fr)
|
2004-04-20 |
2005-11-03 |
Atherogenics, Inc. |
Procede de preparation d'esters et d'ethers de probucol et de ses derives
|
WO2006063408A1
(fr)
*
|
2004-12-17 |
2006-06-22 |
Stocker Ronald O |
Préparations et méthodes pour le traitement de troubles cardio-vasculaires
|
JP2010522762A
(ja)
|
2007-03-26 |
2010-07-08 |
サルトリア・フアーマシユーテイカルズ・エル・エル・シー |
糖尿病の治療のための方法及びプロブコール誘導体の組成物
|